TY - JOUR
T1 - Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery
AU - Kertai, Miklos D.
AU - Li, Yi Ju
AU - Li, Yen Wei
AU - Ji, Yunqi
AU - Alexander, John
AU - Newman, Mark F.
AU - Smith, Peter K.
AU - Joseph, Diane
AU - Mathew, Joseph P.
AU - Podgoreanu, Mihai V.
N1 - Publisher Copyright:
© 2015, BMJ Publishing Group. All rights reserved.
PY - 2015
Y1 - 2015
N2 - Objectives: Identification of patient subpopulations susceptible to develop myocardial infarction (MI) or, conversely, those displaying either intrinsic cardioprotective phenotypes or highly responsive to protective interventions remain high-priority knowledge gaps. We sought to identify novel common genetic variants associated with perioperative MI in patients undergoing coronary artery bypass grafting using genome-wide association methodology. Setting: 107 secondary and tertiary cardiac surgery centres across the USA. Participants: We conducted a stage I genome-wide association study (GWAS) in 1433 ethnically diverse patients of both genders (112 cases/1321 controls) from the Genetics of Myocardial Adverse Outcomes and Graft Failure (GeneMAGIC) study, and a stage II analysis in an expanded population of 2055 patients (225 cases/1830 controls) combined from the GeneMAGIC and Duke Perioperative Genetics and Safety Outcomes (PEGASUS) studies. Patients undergoing primary non-emergent coronary bypass grafting were included. Primary and secondary outcome measures: The primary outcome variable was perioperative MI, defined as creatine kinase MB isoenzyme (CK-MB) values ≥10x upper limit of normal during the first postoperative day, and not attributable to preoperative MI. Secondary outcomes included postoperative CK-MB as a quantitative trait, or a dichotomised phenotype based on extreme quartiles of the CK-MB distribution. Results: Following quality control and adjustment for clinical covariates, we identified 521 single nucleotide polymorphisms in the stage I GWAS analysis. Among these, 8 common variants in 3 genes or intergenic regions met p<10-5 in stage II. A secondary analysis using CK-MB as a quantitative trait (minimum p=1.26×10-3 for rs609418), or a dichotomised phenotype based on extreme CK-MB values (minimum p=7.72×10-6 for rs4834703) supported these findings. Pathway analysis revealed that genes harbouring top-scoring variants cluster in pathways of biological relevance to extracellular matrix remodelling, endoplasmic reticulum-to-Golgi transport and inflammation.
AB - Objectives: Identification of patient subpopulations susceptible to develop myocardial infarction (MI) or, conversely, those displaying either intrinsic cardioprotective phenotypes or highly responsive to protective interventions remain high-priority knowledge gaps. We sought to identify novel common genetic variants associated with perioperative MI in patients undergoing coronary artery bypass grafting using genome-wide association methodology. Setting: 107 secondary and tertiary cardiac surgery centres across the USA. Participants: We conducted a stage I genome-wide association study (GWAS) in 1433 ethnically diverse patients of both genders (112 cases/1321 controls) from the Genetics of Myocardial Adverse Outcomes and Graft Failure (GeneMAGIC) study, and a stage II analysis in an expanded population of 2055 patients (225 cases/1830 controls) combined from the GeneMAGIC and Duke Perioperative Genetics and Safety Outcomes (PEGASUS) studies. Patients undergoing primary non-emergent coronary bypass grafting were included. Primary and secondary outcome measures: The primary outcome variable was perioperative MI, defined as creatine kinase MB isoenzyme (CK-MB) values ≥10x upper limit of normal during the first postoperative day, and not attributable to preoperative MI. Secondary outcomes included postoperative CK-MB as a quantitative trait, or a dichotomised phenotype based on extreme quartiles of the CK-MB distribution. Results: Following quality control and adjustment for clinical covariates, we identified 521 single nucleotide polymorphisms in the stage I GWAS analysis. Among these, 8 common variants in 3 genes or intergenic regions met p<10-5 in stage II. A secondary analysis using CK-MB as a quantitative trait (minimum p=1.26×10-3 for rs609418), or a dichotomised phenotype based on extreme CK-MB values (minimum p=7.72×10-6 for rs4834703) supported these findings. Pathway analysis revealed that genes harbouring top-scoring variants cluster in pathways of biological relevance to extracellular matrix remodelling, endoplasmic reticulum-to-Golgi transport and inflammation.
UR - http://www.scopus.com/inward/record.url?scp=84930226505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930226505&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2014-006920
DO - 10.1136/bmjopen-2014-006920
M3 - Article
C2 - 25948407
AN - SCOPUS:84930226505
SN - 2044-6055
VL - 5
JO - BMJ Open
JF - BMJ Open
IS - 5
M1 - e006920
ER -